Roles of Cytochromes P450 1A2, 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes
Top Cited Papers
- 1 December 2000
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (12) , 1457-1463
- https://doi.org/10.1016/s0090-9556(24)13674-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetineEuropean Journal of Clinical Pharmacology, 1996
- Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymesChemical Research in Toxicology, 1991
- Interactions between UFT and anticoagulants in lung cancer patientsSurgery Today, 1988
- Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinomaGastroenterologia Japonica, 1987
- Metabolic activation of ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil]: the microsomal oxidative pathwayBiochemical Pharmacology, 1982
- The Pharmacology of Ftorafur (R, S-1-(Tetrahydro-2-Furanyl)-5-Fluorouracil)Published by Springer Nature ,1981
- Results of treatment of malignant tumors with ftorafurCancer, 1972
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951